Buying back shares: share count down 3.4% in 3 years
Watch out for
Bills due within a year exceed short-term assets
Money moves
No insider buying or selling in the last 30 days
Institutions cut 32% from their holdings in the quarter ending June 2026 (9 bought, 6 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$0.62+14.8% that day
Company value
$2M
Share price times all shares
Price vs sales
0.21x
No profit over the last year, so this compares value with sales instead
Debt vs value
57%
Debt as a share of company value
From IVF's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$2.2M+17% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $7.5M, up 14% from the 12 months before.
What the price assumes
Your guesses, our math
Move the sliders to your own view of IVF. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$15M
Profit in 5 years$1M
Price these guesses point to$9.12+1371% vs $0.62 todayAbout +71% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 33% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
The checklist Warren Buffett-style investors use. Annual numbers for 2025.
2/4Mixed
PassDebt under half of equityNot relying on borrowed money.0.12x equity
MissProfitable every yearSteady profits, not one good year.3 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$7.1M
PassShare count not growingNot diluting owners. Falling means buybacks.-3.4% in 3 years
Revenue
$6.8M
Total debt
$892K
0.12x equity
Current ratio
0.27x
short-term assets / bills due
Free cash flow
-$7.1M
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, net margin 10%+, gross margin 40%+. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026
Reported Aug 17
Revenue
$2.2M
+16.7% YoY
EPS
$0.35
vs -$728.46
Op. margin
-59.3%
+101.1 pts
Gross margin
97.2%
-2.6 pts
Free cash flow
-$1.1M
Share count
+52074.4%
vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trend
No trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
This week
0
Normal week
0.9
vs normal
0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-31.8%
Institutions cut 31.8% from their holdings. 9 bought, 6 sold. 2 quarters of net selling in a row.
Shares held by institutions131K
Sep '24Jun '26
Safety check
From SEC filings
Share count growthYearly rate, last 3 years
+101.4%
Cash runwayAt last year's cash burn
6 months
Debt to equityLatest balance sheet: debt compared with what owners have
0.1x · $1.6M debt
Shares outstandingLatest reported
3M
Why high risk
Losing money, losses are large next to sales
About 6 months of cash left at its current burn
Share count growing 101.4% a year (dilution)
Bills due within a year exceed short-term assets
3 offering filings in 6 months (may sell new shares)
Past financials no longer reliable
Late quarterly report notice
Exchange listing notice (a delisting warning or a move to another exchange)
Late annual report notice
Earnings reports
Last 12
Next reportAround Nov 16 (est.)Estimated from the same quarter last year
Results filedAug 17
Results filedJun 22
Results filedJun 2
Results filedNov 17, 2025
Results filedAug 15, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days